TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SinoMab Bioscience Ltd. ( (HK:3681) ) has provided an announcement.
SinoMab BioScience Limited has entered into a three-year strategic cooperation agreement with Sun Yat-sen University Institute of Advanced Studies Hong Kong to conduct joint research and development in biomedicine. This collaboration aims to leverage mutual expertise in scientific research, drug development, and technical support, with a focus on advancing therapeutics for debilitating diseases. The agreement includes joint usage of facilities, training programs, and a funding commitment from SinoMab to support the projects, enhancing the company’s operational capabilities and industry positioning.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Limited is a Hong Kong-based company operating in the biomedicine industry, focusing on the research and development of therapeutic products for debilitating diseases.
Average Trading Volume: 17,509,897
Technical Sentiment Signal: Buy
Current Market Cap: HK$3.64B
For an in-depth examination of 3681 stock, go to TipRanks’ Overview page.